Visceral leishmaniasis mimicking autoimmune hepatitis, primary biliary cirrhosis, and systemic lupus erythematosus overlap

Korean Journal of Parasitology

Volumn 50, Issue 2, 2012, Pages 133-136

  Tunccan, Ozlem Guzel ^a   Tufan, Abdurrahman ^a   Telli, Gülçin ^a   Akyürek, Nalan ^a   Pamukçuoǧlu, Merve ^a   Yilmaz, Güldal ^a   Hizel, Kenan ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Autoimmune hepatitis; Leishmania; Primary biliary cirrhosis; Systemic lupus erythematosus; Visceral leishmaniasis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; AMPHOTERICIN B LIPID COMPLEX; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; C REACTIVE PROTEIN; CREATININE; FLUCONAZOLE; GAMMA GLUTAMYLTRANSFERASE; GLOBULIN; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN; IMMUNOGLOBULIN G; LACTATE DEHYDROGENASE; MITOCHONDRION ANTIBODY; PREDNISONE; RHEUMATOID FACTOR; SMOOTH MUSCLE ANTIBODY; SULPERAZON; TEICOPLANIN;

ADULT; ANOREXIA; ARTHRITIS; ARTICLE; AUTOIMMUNE HEPATITIS; BLOOD CELL COUNT; BONE MARROW BIOPSY; CASE REPORT; CONTROLLED STUDY; COOMBS TEST; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; FEBRILE NEUTROPENIA; FEMALE; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; HYPERTRANSAMINASEMIA; IMMUNOSUPPRESSIVE TREATMENT; LEISHMANIA; LIVER BIOPSY; LYMPHOCYTIC INFILTRATION; MEDICAL HISTORY; NEUTROPENIA; NONHUMAN; PHYSICAL EXAMINATION; PRIMARY BILIARY CIRRHOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; URINARY TRACT INFECTION; VISCERAL LEISHMANIASIS;

ADULT; AUTOANTIBODIES; BONE MARROW; CYTOLOGICAL TECHNIQUES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPATITIS, AUTOIMMUNE; HISTOCYTOCHEMISTRY; HUMANS; LEISHMANIASIS, VISCERAL; LIVER; LIVER CIRRHOSIS, BILIARY; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 84862693974     PISSN: 00234001     EISSN: 17380006     Source Type: Journal    
DOI: 10.3347/kjp.2012.50.2.133     Document Type: Article

References (15)

1. Magi{dotless}ll AJ. Leishmania species: visceral (kala-azar), cutaneus, and mucocutaneous leishmaniasis. In: Mandell GL, Bennett JE, Dolin R, eds, Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. Philadelphia, USA. Churchill Livingston. 2010, p 3463-3480.
2. Herwaldt BL. Leishmaniasis. Lancet 1999; 354: 1191-1199.
3. Ready PD. Leishmaniasis emergence in Europe. Euro Surveill 2010; 15: 19505.
4. Galvão-Castro B, Sá Ferreira JA, Marzochi KF, Marzochi MC, Cou-tinho SG, Lambert PH. Polyclonal B cell activation, circulating immune complexes and autoimmunity in human american visceral leishmaniasis. Clin Exp Immunol 1984; 56: 58-66.
5. Argov S, Jaffe CL, Krupp M, Slor H, Shoenfeld Y. Autoantibody production by patients infected with Leishmania. Clin Exp Immunol 1989; 76: 190-197.
6. Arlet JB, Capron L, Pouchot J. Visceral leishmaniasis mimicking systemic lupus erythematosus. J Clin Rheumatol 2010; 16: 203-204.
7. Voulgari PV, Pappas GA, Liberopoulos EN, Elisaf M, Skopouli FN, Drosos AA. Visceral leishmaniasis resembling systemic lupus erythematosus. Ann Rheum Dis 2004; 63: 1348-1349.
8. Casato M, de Rosa FG, Pucillo LP, Ilardi I, di Vico B, Zorzin LR, Sorgi ML, Fiaschetti P, Coviello R, Laganà B, Fiorilli M. Mixed cryoglobulinemia secondary to visceral leishmaniasis. Arthritis Rheum 1999; 42: 2007-2011.
9. Dalgic B, Dursun I, Akyol G. A case of visceral leishmaniasis mis-diagnosed as autoimmune hepatitis. Turk J Gastroenterol 2005; 16: 52-53.
10. Bern C, Adler-Moore J, Berenguer J, Boelaert M, den Boer M, Davidson RN, Figueras C, Gradoni L, Kafetzis DA, Ritmeijer K, Rosenthal E, Royce C, Russo R, Sundar S, Alvar J. Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clin Infect Dis 2006; 43: 917-924.
11. Alioglu B, Avci Z, Ozyurek E, Ozbek N. Visceral leishmaniasis presented with Evans syndrome: A case report. Am J Hematol 2007; 82: 1030-1031.
12. Erduran E, Bahadir A, Gedik Y. Kala-azar associated with coombs-positive autoimmune hemolytic anemia in the patients coming from the endemic area of this disease and successful treatment of these patients with liposomal amphotericin B. Pediatr Hematol Oncol 2005; 22: 349-355.
13. Yazici P, Yeniay L, Aydin U, Taşbakan M, Ozütemiz O, Yilmaz R. Visceral leishmaniasis as a rare cause of granulomatosis hepatitis: A case report. Turkiye Parazitol Derg 2008; 32: 12-15.
14. Sakkas LI, Boulbou M, Kyriakou D, Makri I, Sinani C, Germenis A, Stathakis N. Immunological features of visceral leishmaniasis may mimic systemic lupus erythematosus. Clin Biochem 2008; 41: 65-68.
15. Atta AM, Carvalho EM, Jerônimo SM, Sousa Atta ML. Serum mar-kers of rheumatoid arthritis in visceral leishmaniasis: Rheumatoid factor and anti-cyclic citrullinated peptide antibody. J Autoimmun 2007; 28: 55-58.